Literature DB >> 14770308

Expression patterns of erythropoietin and its receptor in the developing midbrain.

W Knabe1, F Knerlich, S Washausen, T Kietzmann, A L Sirén, G Brunnett, H J Kuhn, H Ehrenreich.   

Abstract

The expression patterns of erythropoietin (EPO) and its receptor (EPOR) were investigated in the midbrain and in adjacent parts of the synencephalon and hindbrain of embryonic C57Bl mice. On embryonic (E) day 8 (E8), virtually all neuroepithelial cells expressed EPOR. After neural tube closure, subsets of these cells downregulated EPOR. In contrast, radial glial cells were EPOR-immunolabeled from E11 onwards. Simultaneously, subpopulations of early developing neurons upregulated EPO and expressed HIF-1, known to transcriptionally activate EPO. Three-dimensional reconstructions revealed subpopulations of EPO-expressing neurons: (1) in the trigeminal mesencephalic nucleus (TMN), (2) at the rostral transition of the midbrain and synencephalon, (3) in the basal plate of the midbrain, (4) in the trigeminal motor nucleus, and (5) in the trigeminal principal sensory nucleus. In the rostral midbrain and synencephalon, EPO-immunoreactive neurons were attached to EPOR-expressing radial glial cells. The identity of radial glial cells was proven by their immunoreactivity for antibodies against astrocyte-specific glutamate transporter, brain lipid-binding protein, and nestin. From E12.5 onwards EPOR was downregulated in radial glial cells. Viable neurons of the TMN continued to express EPO and upregulated EPOR. Our findings provide new evidence that components of the EPO system are present in distinct locations of the embryonic brain and, by interactions between neurons and radial glial cells as well as among clustered TMN neurons, may contribute to its morphogenesis. Whether the observed expression patterns of EPO and EPOR may reflect EPO-mediated trophic and/or antiapoptotic effects on neurons is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770308     DOI: 10.1007/s00429-003-0365-y

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  35 in total

1.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

2.  Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.

Authors:  Ahmed Mohyeldin; Huasheng Lu; Clifton Dalgard; Stephen Y Lai; Noam Cohen; Geza Acs; Ajay Verma
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

3.  Erythropoietin Upregulates Brain Hemoglobin Expression and Supports Neuronal Mitochondrial Activity.

Authors:  N K Singhal; K Alkhayer; J Shelestak; R Clements; E Freeman; J McDonough
Journal:  Mol Neurobiol       Date:  2018-03-01       Impact factor: 5.590

4.  Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury.

Authors:  Shenandoah Robinson; Christopher J Corbett; Jesse L Winer; Lindsay A S Chan; Jessie R Maxwell; Christopher V Anstine; Tracylyn R Yellowhair; Nicholas A Andrews; Yirong Yang; Laurel O Sillerud; Lauren L Jantzie
Journal:  Exp Neurol       Date:  2017-12-26       Impact factor: 5.330

5.  Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.

Authors:  Shenandoah Robinson; Jesse L Winer; Justin Berkner; Lindsay A S Chan; Jesse L Denson; Jessie R Maxwell; Yirong Yang; Laurel O Sillerud; Robert C Tasker; William P Meehan; Rebekah Mannix; Lauren L Jantzie
Journal:  J Neurosurg Pediatr       Date:  2016-02-19       Impact factor: 2.375

6.  Functional erythropoietin autocrine loop in melanoma.

Authors:  Suresh M Kumar; Geza Acs; Dong Fang; Meenhard Herlyn; David E Elder; Xiaowei Xu
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  The construction of siRNA plasmid targeting mouse HIF-1alpha and in vitro study of its inhibition effect.

Authors:  Zhen-Yu Ding; Ze-Gui Li; Yi-Zhan Xing; Hua Ji; Hong-Li Li; Zhi-Jie Chang
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

8.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

Review 9.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

Review 10.  Updates on Novel Erythropoiesis-Stimulating Agents: Clinical and Molecular Approach.

Authors:  Zahra Moradi; Amirhosein Maali; Javad Sadeghi Shad; Alireza Farasat; Reza Kouchaki; Mona Moghadami; Mohamad Hosein Ahmadi; Mehdi Azad
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-16       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.